Application no. and date | 15733497.0 (espacenet) (Federated) (European Patent Register), 20150625 | Patent/reg. no. and date | DK/EP 3160978, 20200729 | Publication date | 20170503 | Priority no. and date | IN 2050MU2014, 20140625, GB 201411253, 20140625 | EP pub. no. and date |
EP 3160978 20170503 | Effective date | | Applicant/owner | NuCana plc, 3 Lochside Way
Edinburgh EH12 9DT, GB | Applicant ref. no. | V2007-090-DK | Inventor | GRIFFITH, Hugh, NuCana BioMed Limited 10 Lochside Place
Edinburgh Scotland EH12 9RG, GB, MCGUIGAN, Christopher, School of Pharmacy and Pharmaceutical Sciences Cardiff University Redwood Building King Edward VII Avenue
Cardiff South Glamorgan CF10 3NB, GB, SLUSARCZYK, Magdalena, School of Pharmacy and Pharmaceutical Sciences Cardiff University Redwood Building King Edward VII Avenue
Cardiff South Glamorgan CF10 3NB, GB, SERPI, Michaela, School of Pharmacy and Pharmaceutical Sciences Cardiff University Redwood Building King Edward VII Avenue
Cardiff South Glamorgan CF10 3NB, GB, FERRARI, Valentina, 83 West Cliff Road
Ramsgate CT11 9NS, GB | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | Opponent | | IPC Class | A61K 31/7068 (2006.01) , A61P 35/00 (2006.01) , C07H 19/10 (2006.01) | Title | GEMCITABIN-PRODRUGS | Int. application no. | GB2015051857 | Int. publication no. | WO2015198058 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|